Exploring Analyst Estimates for FMC (FMC) Q4 Earnings, Beyond Revenue and EPS

03.02.25 15:16 Uhr

Werte in diesem Artikel
Aktien

51,48 EUR -2,76 EUR -5,09%

47,89 EUR -0,24 EUR -0,50%

Indizes

PKT PKT

1.821,7 PKT -26,7 PKT -1,45%

21.428,2 PKT -303,8 PKT -1,40%

8.232,2 PKT -116,7 PKT -1,40%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

193,1 PKT -3,4 PKT -1,71%

534,8 PKT -6,6 PKT -1,22%

11.134,0 PKT -153,4 PKT -1,36%

21.412,5 PKT 8,5 PKT 0,04%

21.413,3 PKT -259,3 PKT -1,20%

8.277,8 PKT -116,9 PKT -1,39%

16.467,6 PKT -134,5 PKT -0,81%

1.854,4 PKT -8,4 PKT -0,45%

6.000,1 PKT -40,5 PKT -0,67%

Wall Street analysts forecast that FMC (FMC) will report quarterly earnings of $1.61 per share in its upcoming release, pointing to a year-over-year increase of 50.5%. It is anticipated that revenues will amount to $1.32 billion, exhibiting an increase of 15.5% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 4.8% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.That said, let's delve into the average estimates of some FMC metrics that Wall Street analysts commonly model and monitor.The consensus estimate for 'Geographic Revenue- Latin America' stands at $516.98 million. The estimate points to a change of +19.5% from the year-ago quarter.Analysts expect 'Geographic Revenue- Europe, Middle East and Africa (EMEA)' to come in at $183.05 million. The estimate suggests a change of +14.7% year over year.Analysts' assessment points toward 'Geographic Revenue- Asia' reaching $273.66 million. The estimate suggests a change of -1.7% year over year.Based on the collective assessment of analysts, 'Geographic Revenue- North America' should arrive at $347.53 million. The estimate points to a change of +26.2% from the year-ago quarter.View all Key Company Metrics for FMC here>>>Over the past month, shares of FMC have returned +14.9% versus the Zacks S&P 500 composite's +2.7% change. Currently, FMC carries a Zacks Rank #5 (Strong Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report FMC Corporation (FMC): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf FMC

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf FMC

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Fresenius Medical Care (FMC) St.

Wer­bung

Analysen zu Fresenius Medical Care (FMC) St.

DatumRatingAnalyst
31.01.2025Fresenius Medical Care (FMC) St NeutralUBS AG
30.01.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
29.01.2025Fresenius Medical Care (FMC) St Market-PerformBernstein Research
28.01.2025Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
28.01.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
DatumRatingAnalyst
30.01.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
28.01.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
21.01.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
06.12.2024Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
02.12.2024Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
23.01.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
15.01.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
15.01.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
17.12.2024Fresenius Medical Care (FMC) St SellWarburg Research
11.12.2024Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care (FMC) St. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"